Pear Therapeutics Inc
NASDAQ:PEAR
Pear Therapeutics Inc
Gross Profit
Pear Therapeutics Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
P
|
Pear Therapeutics Inc
NASDAQ:PEAR
|
Gross Profit
$5.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Veeva Systems Inc
NYSE:VEEV
|
Gross Profit
$1.7B
|
CAGR 3-Years
17%
|
CAGR 5-Years
22%
|
CAGR 10-Years
29%
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Gross Profit
$559.4m
|
CAGR 3-Years
70%
|
CAGR 5-Years
65%
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Gross Profit
$447.3m
|
CAGR 3-Years
23%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Gross Profit
$424.8m
|
CAGR 3-Years
34%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Gross Profit
$683.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
See Also
What is Pear Therapeutics Inc's Gross Profit?
Gross Profit
5.3m
USD
Based on the financial report for Dec 31, 2022, Pear Therapeutics Inc's Gross Profit amounts to 5.3m USD.